H-1B sponsorship profile: Celgene Corporation. Across U.S. Department of Labor LCA disclosures, Celgene Corporation filed 26 Labor Condition Applications covering 26 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 96.2% (25 certified of 26 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Celgene Corporation’s H-1B petitions range from $87,550 at the low end to $218,600 at the high end, with a petition-weighted average of $144,986. That range reflects the mix of occupations the company sponsors, led by Associate Director, Safety Science (4 petitions at $166,036 avg), followed by Senior Manager, Pharmacovigilance Scientist and Senior Manager, Manufacturing IT Systems & MES. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Celgene Corporation is headquartered in Summit, NJ under NAICS code 325412, and places H-1B workers across 3 states, most heavily in NJ, CA, WA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Celgene Corporation ranks. By H-1B petition volume, Celgene Corporation is #8,270 of 119,880 employers nationally and #809 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.